Safety study of MCAM in healthy adults
Part of Mental health clinical trials.
This study tests how safe a new medicine called MCAM is in healthy adults. It looks at how the body processes the medicine and if it causes any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your body mass index (BMI) is between 18 and 32, and you weigh at least 50 kg (110 lbs).
- You are a nonsmoker and have not used tobacco or nicotine products for at least 3 months.
- You are generally healthy, with no significant medical conditions, infections, or recent hospitalizations.
- Your blood pressure, heart rate, and heart rhythm are within normal limits.
- You have not participated in another drug trial within the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests an experimental drug called ACI-19764 to see how safe it is, how the body handles it, and how it affects the immune system. It's for healthy adults and for adults with heart-related risk factors like obesity or type 2 diabetes.
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
This early-stage trial tests a new medicine called GSM-779690T in healthy volunteers to see how safe it is and how the body handles it. Participating could help determine if the medicine is worth testing in people with certain conditions later.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.